Inventor · disambiguated record
Rami Skaliter
Also filed as: SKALITER RAMI
13 granted patents·29 pending applications·229 citations·filing 1996–2023
93Inventor score
Files withQUARK BIOTECH INC9FEINSTEIN ELENA7QUARK PHARMACEUTICALS INC6LINEAGE CELL THERAPEUTICS INC5ASTERIAS BIOTHERAPEUTICS INC2
Top patents by PatentIndex Score
42 records- 0191US6455674B1Hypoxia-regulated genesQUARK BIOTECH INC·Filed 2000·Granted Sep 24, 2002·39 cites·3 claims
- 0290US7259253B2Genes associated with mechanical stress, expression products therefrom, and uses thereofQUARK BIOTECH INC·Filed 2003·Granted Aug 21, 2007·57 cites·18 claims
- 0390US6740738B2Antibody against hypoxia proteinsQUARK BIOTECH INC·Filed 2002·Granted May 25, 2004·33 cites·5 claims
- 0490US6555667B1Hypoxia-regulated genesQUARK BIOTECH INC·Filed 2000·Granted Apr 29, 2003·35 cites·6 claims
- 0589US7872119B2Inhibitors of RTP801 and their use in disease treatmentQUARK PHARMACEUTICALS INC·Filed 2008·Granted Jan 18, 2011·11 cites·13 claims
- 0688US8614309B2Double-stranded RNA directed to CASP2 and methods of use thereofFEINSTEIN ELENA·Filed 2008·Granted Dec 24, 2013·11 cites·34 claims
- 0785US7973156B2Hypoxia-regulated genesQUARK PHARMACEUTICALS INC·Filed 2008·Granted Jul 5, 2011·4 cites·3 claims
- 0884US8067570B2Therapeutic uses of inhibitors of RTP801FEINSTEIN ELENA·Filed 2007·Granted Nov 29, 2011·6 cites·22 claims
- 0981US9056903B2Therapeutic uses of inhibitors of RTP801FEINSTEIN ELENA·Filed 2011·Granted Jun 16, 2015·4 cites·19 claims
- 1081US7524935B2Sequences characteristic of hypoxia-regulated gene transcriptionQUARK PHARMACEUTICALS INC·Filed 2006·Granted Apr 28, 2009·1 cites·10 claims
- 1179US7074895B2Sequences characteristic of hypoxia-regulated gene transcriptionQUARK BIOTECH INC·Filed 2001·Granted Jul 11, 2006·3 cites·1 claims
- 1271US6403316B1Isolation of cDNA encoding for secreted or membranal proteinsQUARK BIOTECH INC·Filed 2000·Granted Jun 11, 2002·4 cites·5 claims
- 1364US2009264634A1Sequences characteristic of hypoxia-regulated gene transcriptionQUARK PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1464US2009162365A1Novel siRNAS and methods of use thereofFEINSTEIN ELENA·Filed 2007·Application pending·0 cites
- 1562US2024382529A1Compositions and methods for treating spinal cord injuriesASTERIAS BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1660US2009156524A1Novel siRNAS and methods of use thereofFEINSTEIN ELENA·Filed 2008·Application pending·0 cites
- 1759US2025262248A1Methods and compositions for treating vision lossCELL CURE NEUROSCIENCES LTD·Filed 2023·Application pending·0 cites
- 1858US2023086868A1Methods and compositions for treating retinal diseases and conditionsLINEAGE CELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1958US2025057886A1Methods and compositions for treating hearing lossLINEAGE CELL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2056US6013437AMethod for identifying translationally regulated genesQ B I ENTERPRISES LTD·Filed 1996·Granted Jan 11, 2000·21 cites·20 claims
- 2155US2023210978A1A universal adoptive immunotherapy approach to treat covid-19 and future emerging infectious diseasesBINETTE FRANCOIS·Filed 2021·Application pending·0 cites
- 2255US2005004065A1Hypoxia regulated genesQUARK BIOTECH INC·Filed 2004·Application pending·0 cites
- 2354US2024082311A1Compositions and methods for treating spinal cord injuriesASTERIAS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2453US2004137608A1Chemical microarrays and method for constructing sameFiled 2003·Application pending·0 cites
- 2552US2011028531A1Novel sirna compounds for inhibiting rtp801FEINSTEIN ELENA·Filed 2009·Application pending·0 cites
- 2652US2011251260A1NOVEL siRNAS AND METHODS OF USE THEREOFQUARK PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 2752US2024158745A1Methods of generating oligodendrocyte progenitor cells and use thereofLINEAGE CELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2851US2009258021A1Genes associated with mechanical stress, expression products therefrom, and uses thereofQUARK BIOTECH INC·Filed 2007·Application pending·0 cites
- 2949US2013123334A1Novel sirna structuresFEINSTEIN ELENA·Filed 2012·Application pending·0 cites
- 3049US2024299625A1Methods and compositions for treating retinal diseases and conditionsLINEAGE CELL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3149US2023313127A1Compositions and methods for embryonic stem cell expansionLINEAGE CELL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3248US2010215588A1Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory systemSKALITER RAMI·Filed 2008·Application pending·0 cites
- 3348US2003104973A1Hypoxia-regulated genesQUARK BIOTECH INC·Filed 2002·Application pending·0 cites
- 3446US2002098488A1ATM mutations in breast cancerFiled 2001·Application pending·0 cites
- 3546US2003157111A176A11 polypeptide and uses thereofFiled 2002·Application pending·0 cites
- 3645US2011098337A1Inhibitors of RTP801 and their use in disease treatmentQUARK PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3745US2004053311A1Methods for identifying phenotype and protein activity inhibitorsFiled 2003·Application pending·0 cites
- 3845US2002137705A1Genes associated with mechanical stress, expression products therefrom, and uses thereofFiled 2001·Application pending·0 cites
- 3942US2002037511A1Method for identifying genesFiled 2001·Application pending·0 cites
- 4041US2002086825A1Genes associated with mechanical stress, expression products therefrom, and uses thereofFiled 2001·Application pending·0 cites
- 4140US2002022026A1Genes associated with mechanical stress, expression products therefrom, and uses thereofFiled 2000·Application pending·0 cites
- 4237US2002151514A1Genes associated with mechanical stress, expression products therefrom, and uses thereofFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rami Skaliter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →